Please be advised that Locks Law Firm is now accepting referrals of Risperdal cases. Risperdal is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson. It causes Gynecomastia, the growth of breasts, in males. Risperdal is a mass tort in the Philadelphia Court of Common Pleas. The criteria of cases worthy of filing is very simple: Gynecomastia in males which develops during or shortly after usage of Risperdal. The patent on Risperdal expired in 2008, at which time generics became available. We will review cases where there was only name brand Risperdal usage and also cases with mixed name brand/generic usage. However, due to rulings of the US Supreme Court, we are not presently reviewing cases with generic use only. If you have been contacted by a man who may have been injured by these products, please contact us. For more information please contact Michael Galpern at 856-663-8200 or Michael Leh at 215-893-0100.
At this time, the Locks Law Firm is open for business and is fully functional, despite the COVID-19 pandemic.
Most of our attorneys and staff members are working remotely and we are fully equipped to continue providing all services during this time of uncertainty. As each state's guidelines are updated, we will gradually be returning to work from our four offices. In the meantime, we would ask that you communicate with us by phone, email or fax and we will respond as quickly as possible. Please do not visit our offices at this time without first communicating with a staff member.